[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-356780-105":53,"doc-detail-356780-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","leveraging-scientific-insights-for-better-healthcare-engagement-a-veeva-white-paper","Leveraging Scientific Insights for Better Healthcare Engagement - A VEEVA White Paper","","Medical affairs, positioned as the scientific face of pharmaceutical organizations, develops external relationships that build credibility with key healthcare decision makers. The paper examines how to identify and engage stakeholders through actionable scientific insights, turning engagement outcomes into future opportunities. It focuses on the role of MSLs in creating pharma value, defining scientific insights, and addressing benchmarking and competitive analysis challenges. Emphasis is placed on harmonizing disparate data sources and sharing intelligence to improve product development and commercialization.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/leveraging-scientific-insights-for-better-healthcare-engagement-a-veeva-white-paper/356780/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/leveraging-scientific-insights-for-better-healthcare-engagement-a-veeva-white-paper/356780.png","ImageObject",442,249,{"name":88,"@type":89},"Jordan Avery","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-17","2026-09-23",true,{"@type":98,"interactionType":99,"userInteractionCount":73},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is the core purpose of medical affairs in the paper?","Question",{"text":108,"@type":109},"Medical affairs is positioned to develop and maintain external relationships, building credibility and partnerships with critical healthcare decision makers.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"How do MSLs drive pharma value according to the document?",{"text":113,"@type":109},"MSLs use scientific expertise to engage key decision makers through meaningful peer exchange, and to bring the HCP voice back into their organizations.",{"name":115,"@type":106,"acceptedAnswer":116},"What is a scientific insight, and why is its definition important?",{"text":117,"@type":109},"A scientific insight can include data points, sentiment, individual perceptions, and healthcare trends; the paper notes the definition across medical affairs is inconsistent.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},356780,1792273252,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":73,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":135,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":76},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","A VEEVA WHITE PAPER  \nLeveraging Scientific Insights for Better Healthcare Engagement  \nVEEVA. COM  \nA VEEVA WHITE PAPER  \nSummary .......................................................................................................................................... 3  \nMSLs as the Driver of Pharma Value ............................................................................................. 3  \nWhat is a Scientific Insight?........................................................................................................... 4  \nIndustry Benchmarking and Competitive Analysis...................................................................... 7  \nConclusion ....................................................................................................................................... 9  \nVEEVA . COM 2  \nA VEEVA WHITE PAPER  \nSummary  \nAs the scientific face of a pharmaceutical organization, medical affairs is uniquely positioned to effectively develop and maintain external relationships, building credibility and partnerships with critical healthcare decision makers. In today’s complex environment, organizations are developing more strategic approaches to generating actionable scientific insights which can translate into future opportunities. This paper explores new concepts for identifying and engaging key stakeholders, leveraging opportunities learned through scientific engagement, and increasing the strategic value of medical affairs.  \nMSLs as the Driver of Pharma Value  \nElite academic institutions are more likely to restrict access to pharmaceutical sales representatives, according to industry research. This trend holds consistent with physicians from highly specialized concentrations, including oncology and nephrology.1  \nAs life sciences’ pipelines continue to shift from small molecules to ones with greater focus on rare diseases, it is critical to understand and engage thought leaders to support scientific exchange leading to improved patient outcomes.  \nHowever, while rep accessibility has declined, this trend is reversed when it comes to medical affairs. This increased complexity of pipelines, coupled with the greater accessibility of medical information by patients, means healthcare providers (HCPs) need deeper support from their medical science liaisons (MSLs) . Because of their scientific expertise, MSLs have the unique opportunity to engage the most critical decision makers in meaningful peer exchange, bringing the voice of the HCP back to their organizations.  \nDeveloping insight from these engagements, and serving as life sciences’ strategic partner to healthcare, is challenging today. Along with the expansion of stakeholder networks to include payers, patients, and policy makers, the volume of data captured today is staggering. Recognizing that the technology employed by MSL teams often mirrors that of their commercial counterparts, medical teams may lack the ability to align various sources of insights for a full understanding of healthcare. Information from online interactions, face-to-face engagement, and medical congresses may be captured in disparate systems and never accurately harmonized. In turn, the manner in which this intelligence is shared organizationally may be firewalled, limiting the potential to inform better product development and commercialization.  \nFor years, medical has taken various approaches to distill HCP interaction data into actionable organizational intelligence: the function’s fundamental strategic value in driving objectives. According to a global survey of MSL teams, more than half see the collection of scientific insights as medical affairs’ core responsibility.2 These include economic insights from payers, trial design/labeling insights from regulators, real-world evidence from patient advocates, and HCP insights across all communication channels.  \nTo achieve this, a structure is required make the collection and interpretation of data meaningful. What is","cbCaitT0v3ShiRMb","https://ap.wps.com/l/cbCaitT0v3ShiRMb","pdf",855100,9,"English","# Summary\n## MSLs as the Driver of Pharma Value\n## What is a Scientific Insight?\n## Industry Benchmarking and Competitive Analysis\n## Conclusion","[{\"question\":\"What is the core purpose of medical affairs in the paper?\",\"answer\":\"Medical affairs is positioned to develop and maintain external relationships, building credibility and partnerships with critical healthcare decision makers.\"},{\"question\":\"How do MSLs drive pharma value according to the document?\",\"answer\":\"MSLs use scientific expertise to engage key decision makers through meaningful peer exchange, and to bring the HCP voice back into their organizations.\"},{\"question\":\"What is a scientific insight, and why is its definition important?\",\"answer\":\"A scientific insight can include data points, sentiment, individual perceptions, and healthcare trends; the paper notes the definition across medical affairs is inconsistent.\"}]","Leveraging Scientific Insights for Better Healthcare Engagement - A VEEVA White Paper | PDF",1790127273]